Hepatic abscess due to Brucella species is an extremely rare complication especially in acute illness. Here, we report a case of hepatic microabscesses probably caused by Brucella in a 33-year-old woman with acute infection who was successfully treated with a combination of doxycycline and rifampicin for 3 months.
Introduction
Brucellosis is a systemic infection that may affect any organ or system of the human body. Hepatic involvement is frequent in both acute and chronic brucellosis. Usually, a slight increase in the liver function tests and mild hepatosplenomegaly occur, and sometimes, acute hepatitis develops, but hepatic abscess is a rare manifestation of that disease [1] [2] [3] . This report describes a hepatic microabscesses probably due to brucellosis in a 33-yearold woman.
Case Report
A 33-year-old woman was admitted to our university hospital with the complaints of temperature up to 40°C, headache, nausea, and weakness for 2 weeks. She had a history of raising livestock and lived in rural area. On physical examination, there was no abnormal finding except right upper quadrant mild tenderness. The laboratory data were as follows: total leukocyte count, 5600/ mm 3 (4000-10,000/mm 3 ); differential leukocyte count: neutrophils, 54%; lymphocytes, 36%; monocytes, 8%; basophils, 0.3%; eosinophils, 1.7%; platelets, 285,000/mm (Fig. 1 ).With these findings, the patient was diagnosed as having hepatic microabscesses due to brucellosis. Doxycycline (2 9 100 mg/day p.o.) and rifampicin (1 9 600 mg/day p.o.) combination was started. The patient received this treatment for 3 months. On the fifty-ninth day of the treatment, the levels of serum alanine transferase level and serum aspartate transferase decreased to the reference range. The repeated ultrasonography at the end of the treatment showed normal result.
Discussion
Brucellosis is a zoonosis that has been virtually eliminated from most developed countries, but it is still endemic in many regions of the world including Mediterranean areas, in parts of South and Central America, and East and Western Africa. The disease is transmitted to man mainly after consumption of contaminated unpasteurized milk and dairy products and less often after direct contact with infected animals [1] .
Hepatic involvement in brucellosis covers a wide spectrum, ranging from mild elevation of aminotransferases to hepatitis including granulomatous forms and to liver abscesses. Increases in aminotransferases are noted in one-fourth to one-third of brucellosis cases and are more frequent in the acute stages. All cases with elevated liver enzymes should not be evaluated as hepatic involvement. Hepatic involvement in brucellosis has been reported in the literature in around 2-3% of the cases. Although B. abortus tends to establish a granulomatous form of hepatitis, B. melitensis may cause both diffuse and granulomatous lesions in the liver [1] [2] [3] [4] . An abscess caused by Brucella spp usually represents the chronic form of disease, but it can occur in acute or subacute brucellosis.
Most of the clinical signs and symptoms of hepatic abscess are nonspecific. In most reported cases of brucellar abscess, fever is the main symptom. Two-thirds of patients had prolonged, slight pain in the right upper abdominal quadrant. Routine laboratory findings in brucellosis are not usually diagnostic that may include leukopenia, anemia, thrombocytopenia, pancytopenia, and mild-to-moderate elevation of liver function tests [2, 5, 6] . Ultrasonography and computed tomography images are characteristic. Ultrasonography most commonly shows a single, hypoechoic lesion with ≥1 centrally located calcium deposits. Computed tomography findings most commonly depict a hypodense area, and often one or more saccular, loculated, heterogeneous mass, and one or more calcifications [5, 6] .
The diagnosis of brucellosis can be established according to the isolation of Brucella spp. in blood, bone marrow or any other body fluid or tissue sample, or the presence of a compatible clinical picture with the demonstration of specific antibodies at significant titers or seroconversion. Significant titers are considered to be a standard agglutination test (SAT) result ≥1/160 or a Coombs' anti-Brucella or immunocapture agglutination test result ≥1/320 [1, 6] . The best regimen for the treatment of localized lesions has not been clearly defined. There is no consensus on the optimal duration of antimicrobial treatment. The duration of treatment varies depending on the individual case and the response to treatment [1] . Small, multifocal abscesses which can be detected in the acute forms of the disease respond very well to medical treatment. Other types of abscesses with an indolent course have a much worse prognosis, which considered to be a true focal complications of the disease. However, no clear distinction is made of these groups [7] . In this case, the short duration of symptoms and the high titer of Brucella agglutination test suggest that this case was acute. It was identified multiple millimetric foci were more prominent in the right lobe of the liver parenchyma to be significant in terms of microabscesses. Our patient was successfully treated with a combination of doxycycline and rifampicin for 3 months. The diagnosis of brucellosis in our case was confirmed with clinical findings, livestock farming history, positive serological tests, and complete response to medical treatment.
In conclusion, brucellosis is a systemic infectious disease and it is still an important public health problem in endemic areas of the world including Turkey that can cause serious complications and significant morbidity. Clinicians should be considered in the differential diagnosis of this unusual complication of brucellosis for those who live in or have visited endemic areas.
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